Polimorfismos do gene carregador de folato reduzido (RFC1) A80G e transcobalamina 2 (TC2) C776G na etiologia da síndrome de Down
Palavras-chave:
Síndrome de Down, Polimorfismo genético, Ácido fólico, Não-disjunção genética, TranscobalaminasResumo
CONTEXTO E OBJETIVO: Considerando as evidências de que polimorfismos em genes envolvidos no metabolismo do folato podem estar associados ao risco materno elevado para a síndrome de Down (SD), o objetivo deste estudo foi investigar os polimorfismos A80G do gene carregador de folato reduzido 1 (RFC1) e C776G do gene transcobalamina 2 (TC2) como fatores de risco maternos para a SD em mulheres brasileiras. TIPO E ESTUDO LOCAL: Estudo transversal analítico com grupo controle, realizado na Faculdade de Medicina de São José do Rio Preto (Famerp). MÉTODOS: Foram avaliadas 67 mães de indivíduos com trissomia livre do 21 e 113 mães de indivíduos sem a síndrome. A análise molecular dos polimorfismos foi realizada pela técnica de reação em cadeia da polimerase/polimorfismo de comprimento fragmentos de restrição (PCR-RFLP), seguida por eletroforese em gel de agarose 2%. RESULTADOS: As freqüências dos alelos polimórficos foram de 0,51 e 0,52 para RFC1 80G e 0,34 e 0,34 para TC2 776G nos grupos caso e controle, respectivamente. Assim, não houve diferença nas freqüências alélicas e genotípicas para ambos os polimorfismos entre os grupos (P = 0,696 para RFC1 A80G; P = 0,166 para TC2 C776G; p = 0,268 para genótipos combinados). CONCLUSÃO: Não há evidência de associação entre os polimorfismos RFC1 A80G e TC2 C776G e o risco materno para a SD na casuística avaliada.
Downloads
Referências
Oliver TR, Feingold E, Yu K, et al. New insights into human nondisjunction of chromosome 21 in oocytes. PLoS Genet. 2008;14;4(3):e1000033.
Jyothy A, Kumar KS, Mallikarjuna GN, et al. Parental age and the origin of extra chromosome 21 in Down syndrome. J Hum Genet. 2001;46(6):347-50.
Gusmão FA, Tavares EJ, Moreira LM. Idade materna e sín- drome de Down no Nordeste do Brasil. [Maternal age and Down syndrome in Northeast Brazil]. Cad Saude Publica. 2003;19(4):973-8.
Beiguelman B, Krieger H, Silva LM. Maternal age and Down syndrome in Southeastern Brazil. Rev Bras Genet = Braz J Genet. 1996;19(4):637-40.
Fenech M. Micronutrients and genomic stability: a new para- digm for recommended dietary allowances (RDAs). Food Chem Toxicol. 2002;40(8):1113-7.
Finkelstein JD, Martin JJ. Homocysteine. Int J Biochem Cell Biol. 2000;32(4):385-9.
D’Alessio AC, Szyf M. Epigenetic tête-à-tête: the bilateral rela- tionship between chromatin modifications and DNA methyla- tion. Biochem Cell Biol. 2006;84(4):463-76.
Sciandrello G, Caradonna F, Mauro M, Barbata G. Arsenic- induced DNA hypomethylation affects chromosomal instability in mammalian cells. Carcinogenesis. 2004;25(3):413-7.
Biselli JM, Goloni-Bertollo EM, Zampieri BL, Haddad R, Eberlin MN, Pavarino-Bertelli EC. Genetic polymorphisms involved in folate metabolism and elevated plasma concentra- tions of homocysteine: maternal risk factors for Down syndrome in Brazil. Genet Mol Res. 2008;7(1):33-42.
Coppedè F, Marini G, Bargagna S, et al. Folate gene polymor- phisms and the risk of Down syndrome pregnancies in young Italian women. Am J Med Genet A. 2006;140(10):1083-91.
da Silva LR, Vergani N, Galdieri L de C, et al. Relationship between polymorphisms in genes involved in homocysteine metabolism and maternal risk for Down syndrome in Brazil. Am J Med Genet A. 2005;135(3):263-7.
Acácio GL, Barini R, Bertuzzo CS, Couto EC, Annichino- Bizzacchi JM, Júnior WP. Methylenetetrahydrofolate reductase gene polymorphisms and their association with trisomy 21. Prenat Diagn. 2005;25(13):1196-9.
Fillon-Emery N, Chango A, Mircher C, et al. Homocysteine concentrations in adults with trisomy 21: effect of B vitamins and genetic polymorphisms. Am J Clin Nutr. 2004;80(6):1551-7.
Chango A, Emery-Fillon N, de Courey GP, et al. A polymor- phism (80G-A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab. 2000;70(4):310-5.
Nguyen TT, Dyer DL, Dunning DD, Rubin SA, Grant KE, Said HM. Human intestinal folate transport: cloning, expression, and distribution of complementary RNA. Gastroenterology. 1997;112(3):783-91.
Miller JW, Ramos MI, Garrod MG, Flynn MA, Green R. Transcobalamin II 775GC polymorphism and indices of vita- min B12 status in healthy older adults. Blood. 2002;100(2):718- 20.
Afman LA, Lievers KJ, van der Put NM, Trijbels FJ, Blom HJ. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet. 2002;10(7):433-8.
Yamada K, Gravel RA, Toraya T, Matthews RG. Human methionine synthase reductase is a molecular chaperone for human methionine synthase. Proc Natl Acad Sci U S A. 2006;103(25):9476-81.
Miller SA, Dykes DD, Polesky HF. A simple salting out proce- dure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Födinger M, Dierkes J, Skoupy S, et al. Effect of glutamate carboxypeptidase II and reduced folate carrier polymorphisms on folate and total homocysteine concentrations in dialysis patients. J Am Soc Nephrol. 2003;14(5):1314-9.
Pietrzyk JJ, Bik-Multanowski M. 776CG polymorphism of the transcobalamin II gene as a risk factor for spina bifida. Mol Genet Metab. 2003;80(3):364.
Coelho IS. Doenças cromossômicas. Available from: http://www. ufv.br/dbg/BIO240/DC14.htm. Accessed in 2008 (Sep 10).
Barros ACSD, Zugaib M, Pereira PP, Guglielmi GF, Durante AA. Gestantes de pelo menos 45 anos de idade: considerações sobre 40 casos. [Pregnant women of 45 or more. Considerations on 40 cases]. J Bras Ginecol. 1984;94(1/2):33-6.
Hansen JP. Older maternal age and pregnancy outcome: a review of the literature. Obstet Gynecol Surv. 1986;41(11):726-42.
Kiely JL, Paneth N, Susser M. An assessment of the effects of maternal age and parity in different components of perinatal mortality. Am J Epidemiol. 1986;123(3):444-54.
Schupp T. Espaço médico: idade materna avançada. Avail- able from: http://drauziovarella.ig.com.br/espaco/espaco. asp?doe_id=25. Accessed in 2008 (Sep 10).
Castilla EE, Lopez-Camelo JS, Paz JE. Atlas geográfico de las malformaciones congénitas en sudamérica. Rio de Janeiro: Fiocruz; 1995.
Eskes TK. Abnormal folate metabolism in mothers with Down syndrome offspring: review of the literature. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):130-3.
James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr. 1999;70(4):495-501.
Chango A, Fillon-Emery N, Mircher C, et al. No association between common polymorphisms in genes of folate and homo- cysteine metabolism and the risk of Down’s syndrome among French mothers. Br J Nutr. 2005;94(2):166-9.
Whetstine JR, Gifford AJ, Witt T, et al. Single nucleotide poly- morphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res. 2001;7(11):3416-22.
Guéant-Rodriguez RM, Rendeli C, Namour B, et al. Transco- balamin and methionine synthase reductase mutated polymor- phisms aggravate the risk of neural tube defects in humans. Neurosci Lett. 2003;344(3):189-92.
Barkai G, Arbuzova S, Berkenstadt M, Heifetz S, Cuckle H. Frequency of Down’s syndrome and neural-tube defects in the same family. Lancet. 2003;361(9366):1331-5.
Guéant JL, Guéant-Rodriguez RM, Anello G, et al. Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin Chem Lab Med. 2003;41(11):1473-7.
De Wals P, Tairou F, Van Allen MI, et al. Reduction in neural- tube defects after folic acid fortification in Canada. N Engl J Med. 2007;357(2):135-42.
Pitkin RM. Folate and neural tube defects. Am J Clin Nutr. 2007;85(1):285S-288S.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
